Actively Recruiting
Study of Rhinovirus Effects on COPD Flare-Ups to Find New Treatments Using Advanced Biological Analysis
Led by Imperial College London · Updated on 2026-04-14
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating exacerbations of chronic obstructive pulmonary disease COPD caused by rhinovirus, a common cold virus, to find new treatments. Exacerbations are flare-ups of respiratory symptoms that significantly impact people with COPD and are mostly triggered by viruses. The study compares people with COPD to healthy volunteers to understand the bodys response to rhinovirus and why COPD patients experience more severe symptoms and flare-ups. All participants will be inoculated with rhinovirus-A16 through a nasal spray. The study includes groups of people with COPD, non-smoking controls, and smoking controls. Before infection, participants undergo a baseline bronchoscopy and other tests. After infection, they will have multiple visits with lung function tests, nasal and throat swabs, blood and sputum samples, and a second bronchoscopy to measure changes in lung and immune responses over 42 days. Participants will attend several study visits from the baseline through day 42, involving physical exams, lung function tests, questionnaires, and sample collections such as nasal washes, blood, urine, and sputum. Researchers will monitor respiratory symptoms daily using scores and assess lung function and immune responses at scheduled intervals. This detailed monitoring aims to identify biological processes linked to COPD exacerbations and support the development of new therapies.
CONDITIONS
Brief Title
Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets
Research Team
D
Dominic P Wilkins, MBBS
C
Carmen Chan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here